This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands. (September 2015)
Record Type:
Journal Article
Title:
1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands. (September 2015)
Main Title:
1223 Cost-effectiveness of radium-223 compared to best standard of care, abiraterone acetate and enzalutamide in the treatment of castration resistant prostate cancer in the Netherlands